Key Takeaways & Executive Findings
- •• SUN5 is a novel regulator of mRNA export in male germ cells, interacting with Nxf1 and Nup93 to facilitate mRNP translocation through the nuclear pore complex. • Loss of SUN5 leads to nuclear accumulation of poly(A)+ RNA and hnRNPs, causing reduced sperm count, motility, and head-to-tail junction defects, linking SUN5 dysfunction to acephalic spermatozoa syndrome. • SUN5 functions via the Nxf1-dependent pathway, not the CRM1 pathway, as demonstrated by leptomycin B treatment and knockout studies. • This study reveals a testis-specific mRNA export mechanism, providing potential therapeutic targets for male infertility and a deeper understanding of spermatogenesis.
Abstract
SUN5, a testis-specific gene, is associated with acephalic spermatozoa syndrome (ASS). Here, we demonstrate that SUN5 is involved in mRNA export. In Sun5-knockout mice (Sun5–/–), poly(A)+ RNA accumulates in the nuclei of germ cells, leading to reduced sperm counts, decreased sperm motility and disrupted sperm head-to-tail junctions. Additionally, in the GC-2 germ cell line with RNA interference of Sun5, heterogeneous nuclear ribonucleoproteins (hnRNPs) and poly (A)+ RNA (mainly mRNA) are retained in the nucleus. Further mechanistic studies reveal that SUN5 interacts with Nxf1 (nuclear RNA export factor 1) and nucleoporin 93 (Nup93). Interference with Nup93 inhibits mRNA export. Treatment with leptomycin B to block the CRM1 pathway indicates that Sun5 regulates mRNA export through an Nxf1-dependent pathway. In Sun5–/– mice, the binding of Nxf1 and Nup93 decreases due to loss of Sun5 function, and the process of submitting Nxf1-binding mRNPs to Nup93 is inhibited, resulting in abnormal spermatogenesis. Together, these data may elucidate a novel pathway for mRNA export in male germ cells.
1. Introduction
Spermatogenesis is a complex process in which spermatogonial stem cells undergo a series of differentiations to produce haploid spermatids, after which the spermatids develop into mature spermatozoa [1]. At each stage, testis-specific genes are involved and exert their specific functions. Genes are transcribed in the nucleus, encased in messenger ribonucleoprotein particles (mRNPs) and translocated to the cytoplasm via the nuclear pore complex (NPC) for immediate translation or storage [2,3]. However, the function and molecular mechanism of these testis-specific genes in mRNA nuclear export are still unclear.
Pre-mRNAs are packaged into mRNPs by loading with different RNA-binding proteins (RBPs). Current studies have demonstrated that in eukaryotes, certain RBPs are deposited at specific locations on pre-mRNAs when transcribed for synthesis [4]. As a large class of RBPs, heterogeneous nuclear ribonucleoproteins (hnRNPs) affect multiple aspects of mRNA metabolism, including the encasing of nascent transcripts, alternative splicing, nucleus-to-cytoplasm transport and translational regulation [5]. In humans, approximately 30 different hnRNPs (called A1 to U) bind to different transcripts synthesized by RNA-pol-II in the nucleus [6]. HnRNPs, such as hnRNP K, depart from mRNPs before being exported or rapidly shuttling back from the cytoplasm to the nucleus [7]. HnRNPs assist in the control of pre-mRNA maturation into mRNAs and accompany the mRNA at different stages [6].
RNA is transported from the nucleus to the cytoplasm in different ways and is broadly categorized into two forms: the chromosomal region maintenance 1 (CRM1) pathway and the nuclear RNA export factor 1 (NXF1) pathway, depending on the transporter receptor [8]. A small subset of mRNAs and various miscellaneous RNAs, such as miRNAs and lncRNAs, are mainly transported by the CRM1 protein, similar to karyopherin [9]. However, the transport of most constitutively expressed mRNAs is mediated by the NXF1-NXT1 heterodimer, despite the variety of mRNAs in terms of splicing, maturation state, size, copy number, etc. [10]. NXF1 consists of four domains: a leucine-rich region (LRR), an RNA recognition motif (RRM), an NTF2-like domain (NTF2L) which binds NXT1 to form the NXF1/NXT1 heterodimer, and a ubiquitin-associated (UBA) domain [11]. In the process of mRNA export, the NXF1-NXT1 heterodimer is loaded onto mRNPs via the transcription export complex (TREX), and mRNPs with export capability are assembled in preparation for translocation [12,13].
Loading authentic research manuscript (Pages 1–5)...
Xiyi He, Yunfei Zhang, Zenghui Mao, Gang Liu, Lihua Huang, Xiaowen Liu, Yuyan Su, Xiaowei Xing (2026). SUN5, a testis-specific nuclear membrane protein, participates in recruitment and export of nuclear mRNA in spermatogenesis. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024134
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the role of SUN5 in mRNA export during spermatogenesis?
SUN5 is a testis-specific nuclear membrane protein that facilitates mRNA export by interacting with Nxf1 and Nup93, ensuring proper translocation of mRNPs through the nuclear pore complex. Loss of SUN5 leads to nuclear retention of mRNA and hnRNPs, causing defective spermatogenesis.
How does SUN5 deficiency affect sperm quality?
SUN5 knockout in mice results in reduced sperm count, decreased sperm motility, and disrupted head-to-tail junctions, which are characteristic features of acephalic spermatozoa syndrome (ASS).
Which pathway does SUN5 utilize for mRNA export?
SUN5 regulates mRNA export through the Nxf1-dependent pathway, not the CRM1 pathway, as demonstrated by leptomycin B treatment and mechanistic studies.
What are the key molecular interactions of SUN5?
SUN5 interacts with Nxf1 (nuclear RNA export factor 1) and nucleoporin 93 (Nup93), and its loss reduces the binding between Nxf1 and Nup93, inhibiting the export of Nxf1-bound mRNPs.
What is the significance of this study for male infertility?
This study identifies a novel testis-specific mRNA export pathway, providing insights into the molecular basis of acephalic spermatozoa syndrome and potential targets for diagnosing or treating male infertility.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.